Xponance’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $318K | Buy |
18,358
+2,261
| +14% | +$39.1K | ﹤0.01% | 1116 |
|
|
2025
Q1 | $352K | Buy |
16,097
+2,025
| +14% | +$44.3K | ﹤0.01% | 1043 |
|
|
2024
Q4 | $449K | Buy |
14,072
+749
| +6% | +$23.9K | ﹤0.01% | 981 |
|
|
2024
Q3 | $384K | Sell |
13,323
-450
| -3% | -$13K | ﹤0.01% | 1016 |
|
|
2024
Q2 | $528K | Buy |
13,773
+968
| +8% | +$37.1K | 0.01% | 896 |
|
|
2024
Q1 | $753K | Sell |
12,805
-122
| -0.9% | -$7.17K | 0.01% | 807 |
|
|
2023
Q4 | $774K | Sell |
12,927
-939
| -7% | -$56.2K | 0.01% | 769 |
|
|
2023
Q3 | $527K | Sell |
13,866
-181
| -1% | -$6.89K | 0.01% | 873 |
|
|
2023
Q2 | $1.28M | Buy |
14,047
+8,632
| +159% | +$786K | 0.02% | 583 |
|
|
2023
Q1 | $357K | Buy |
5,415
+46
| +0.9% | +$3.03K | 0.01% | 1002 |
|
|
2022
Q4 | $278K | Buy |
5,369
+114
| +2% | +$5.9K | ﹤0.01% | 1051 |
|
|
2022
Q3 | $359K | Buy |
5,255
+370
| +8% | +$25.3K | 0.01% | 951 |
|
|
2022
Q2 | $221K | Buy |
+4,885
| New | +$221K | ﹤0.01% | 1076 |
|
|
2021
Q3 | – | Sell |
-3,556
| Closed | -$225K | – | 1179 |
|
|
2021
Q2 | $225K | Buy |
+3,556
| New | +$225K | ﹤0.01% | 1143 |
|